These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 14515035)
1. [Recurrence and management of hepatitis C after liver transplantation]. Oh KB; Lee SG; Lee YJ; Park KM; Hwang S; Kim KH; Ahn CS; Moon DB; Chu CW; Yang HS; Ha TY; Cho SH Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):180-7. PubMed ID: 14515035 [TBL] [Abstract][Full Text] [Related]
2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285 [TBL] [Abstract][Full Text] [Related]
4. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications. Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936 [TBL] [Abstract][Full Text] [Related]
5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [TBL] [Abstract][Full Text] [Related]
6. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation. Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226 [TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313 [TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
9. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis. Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058 [TBL] [Abstract][Full Text] [Related]
10. Liver transplantation and hepatitis C. Willems M; Metselaar HJ; Tilanus HW; Schalm SW; de Man RA Transpl Int; 2002 Mar; 15(2-3):61-72. PubMed ID: 11935162 [TBL] [Abstract][Full Text] [Related]
11. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis. Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133 [TBL] [Abstract][Full Text] [Related]
12. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Russo MW; Galanko J; Beavers K; Fried MW; Shrestha R Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C. Burra P Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659 [TBL] [Abstract][Full Text] [Related]
16. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308 [TBL] [Abstract][Full Text] [Related]
17. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation. Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367 [TBL] [Abstract][Full Text] [Related]
18. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease. Inoue K; Yoshiba M Transplant Proc; 2005 Mar; 37(2):1233-4. PubMed ID: 15848679 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus and liver transplantation: our point of view. Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102 [TBL] [Abstract][Full Text] [Related]
20. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]